Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.313 USD | +39.11% | +81.71% | +104.03% |
04-19 | Venture Life renews revolving credit facility with Santander and HSBC | AN |
04-18 | Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy | CI |
Business Summary
Number of employees: 49
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Health
98.2
%
| 12 | 98.2 % | 10 | 98.2 % | -18.34% |
Animal Health
1.8
%
| 0 | 1.8 % | 0 | 1.8 % | -19.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 12 | 100.0 % | 10 | 100.0 % | -18.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 18-10-31 |
Chief Tech/Sci/R&D Officer | 62 | 21-04-30 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 21-09-08 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 18-03-28 |
Director/Board Member | 67 | 22-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 9 | 0 | 0 | 98.22 % |
Stock B | 1 | 276,216,260 | 271,297,541 ( 98.22 %) | 0 |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+104.03% | 62.15M | |
-1.38% | 104B | |
+6.66% | 97.47B | |
+5.71% | 22.25B | |
-12.58% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.25% | 16.36B | |
+7.56% | 14.39B | |
+37.73% | 12.37B |
- Stock Market
- Equities
- JAGX Stock
- Company Jaguar Health, Inc.